Alnylam Pharmaceuticals (ALNY) EBITDA Margin (2009 - 2026)
Alnylam Pharmaceuticals' EBITDA Margin was 19.00% in Q2 2026, up 19.30 percentage points from -0.29% a year earlier but down 5.17 percentage points from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) EBITDA Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Alnylam Pharmaceuticals' EBITDA Margin was 21.95% through Jun 30, 2026, up 26.84 percentage points year-over-year; for FY2025, it was 15.00%, up 20.35 percentage points from FY2024.
- EBITDA Margin has now increased for seven consecutive years, with a five-year change of +176.04 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -5.35% in FY2024 (+7.13 pp), -12.48% in FY2023 (+58.91 pp), -71.39% in FY2022 (+6.91 pp) and -78.30% in FY2021 (+82.73 pp).
- Quarterly EBITDA Margin has moved between -93.62% (Q3 2022) and 30.57% (Q3 2025) over five years.
- Compared with a year earlier, EBITDA Margin was higher in four of the last six quarters, with an average year-over-year change of +7.72 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2023 (a gain of 123.89 percentage points); the worst was Q3 2024 (a drop of 42.83 percentage points).
- Per Business Quant data, ALNY's EBITDA Margin in the three quarters before Q2 2026 was 24.18% (Q1 2026), 13.24% (Q4 2025) and 30.57% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Alnylam Pharmaceuticals | 20.30 Bn | 7.49 Bn | 1.10 Bn | 24.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 24.71% |
| Jun 30, 2026 | 19.00% |
| Mar 31, 2026 | 24.18% |
| Dec 31, 2025 | 13.24% |
| Sep 30, 2025 | 30.57% |
| Jun 30, 2025 | -0.29% |
| Dec 31, 2024 | -15.34% |
| Sep 30, 2024 | -12.56% |
| Jun 30, 2024 | 9.64% |
| Mar 31, 2024 | -6.05% |
| Dec 31, 2023 | -23.41% |
| Sep 30, 2023 | 30.27% |
| Jun 30, 2023 | -67.97% |
| Mar 31, 2023 | -42.51% |
| Dec 31, 2022 | -52.03% |
| Sep 30, 2022 | -93.62% |
| Jun 30, 2022 | -80.77% |
| Mar 31, 2022 | -64.37% |
| Dec 31, 2021 | -70.86% |
| Sep 30, 2021 | -90.54% |
API Access
Alnylam Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();